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Nitro derivatives of five-membered heterocyles are of considerable interest. Some
are biologically active with anti-inflammatory or vasodilatory activity (1). The 5-nitro-
imidazoles are used as antiamoebic, antiprotozoal and antibacterial agents. Two impor-
tant members of this chemical class are metronidazole and tinidazole. Discovery of the
anti-trichomonal properties of metronidazole revolutionized the treatment of disease.
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A new approach to the spectrophotometric determina-
tion of metronidazole (MZ) and tinidazole (TZ) has been
developed. The procedure involves coupling of diazoti-
zed nitroimidazoles with p-dimethylaminobenzaldehyde
(DMAB) to form a greenish-yellow solution. Optimal
temperature and time were 0 °C (iced) and 3 minutes for
diazotization and 30 °C and 2 minutes for coupling for
both MZ and TZ. Coloured adducts of MZ and TZ sho-
wed shoulders at 406 nm and 404 nm, respectively, which
were selected as analytical wavelengths. The reaction
with p-DMAB occurred in a 1:1 mole ratio. Beer’s law
was obeyed within the 4.8–76.8 mg mL–1 concentration
range with low limits of detection. The azo adducts were
stable for over a week. Molar absorptivities were 1.10 ´
103 (MZ) and 1.30 ´ 103 L mol–1 cm–1 (TZ). Overall recov-
eries of MZ and TZ from quality control samples were
103.2 ± 1.3 and 101.9 ± 1.3 % over three days. There was no
interference from commonly utilized tablet excipients.
No significant difference was obtained between the results
of the new method and the BP titrimetric procedures. The
azo approach using the p-dimethylaminobenzaldehyde
procedure described in this paper is simple, fast, accurate
and precise. It is the first application of DMAB as a cou-
pling component in the diazo coupling reaction.
Keywords: nitroimidazoles, diazotization, spectrophoto-
metry, p-dimethylaminobenzaldehyde
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Chemically, metronidazole is 2-methyl-5-nitroimidazole-1-ethanol (MZ) and tinidazole
is 1-(2-ethyl-sulphonyl ethyl)-2-methyl-5-nitroimidazole (TZ) (2). The biological activity
of nitroimidazoles is dependent upon the nitro group reduction due to the formation of
active intermediate species (3) that interact with DNA to produce biochemical damage.
Reduction of the nitro group has been also used as a basis for determination of these
drugs. Several methods have been reported for the determination of metronidazole
and/or tinidazole in bulk and dosage forms or in biological fluids. Such methods in-
clude non-aqueous titration (4), voltammetric methods (5, 6), HPLC (7) and flow injec-
tion analysis (8). Some previously described spectrophotometric methods include the use
of vanillin and anisaldehyde (9), p-benzoquinone (10), metol and K2Cr2O7 (11), alkaline
hydrolysis (12), derivative spectrophotometry (13), extractive spectrophotometry using
sodium 1,2-naphthaquinone-4-sulfonate after condensation reaction (14) and methylben-
zothiazolin-2-one hydrazine (MBTH) (15) among others. These spectrophotometric me-
thods have their relative merits but the majority of them are carried out at elevated tem-
peratures, time consuming, use relatively expensive reagents, involve extraction, use of
buffer systems, not all determine MZ and TZ and many are multi-step procedures. The
ability of p-dimethylaminobenzaldehyde (DMAB) to form Schiff’s bases with aromatic
amines has been utilized for the spectrophotometric determination of compounds such
as metronidazole (16) and hydralazine (17). In the varied applications of DMAB, none
involved its use as a coupling component to diazonium ion. In this report, we present a
simple, sensitive, cost-effective and accurate determination of nitroimidazoles using DMAB
via azo dye formation.
EXPERIMENTAL
Apparatus and reagents
A UV/VIS spectrophotometer (Unicam Aurora, Pye Unicam, UK) was used. Metro-
nidazole and tinidazole chemical reference substances were used (Sigma, USA). All rea-
gents and solvents used were of analytical grade. The drugs selected for this study were
obtained from pharmaceutical stores in Ibadan, Nigeria and are metronidazole brands:
Loxagyl (May & Baker Ltd., Nigeria), Metrodol (Pauco Pharm. Nigeria Ltd., Nigeria),
Metrotabs (SKG Pharma Ltd., Nigeria), Tromet 500 infusion (Microlabs Ltd. India) while
the tinidazole brand was Amtiba 500 (Cadila Pharm. Dholka, India).
Standard solutions of pure reference metronidazole and tinidazole (1200 mg mL–1,
corresponding to 7 ´ 10–3 and 4.9 ´ 10–3 mol L–1, respectively) were prepared in metha-
nol. A 0.1 % (7.0 ´ 10–3 mol L–1) DMAB solution was prepared in a solution of optimized
sulphuric acid concentration of 0.5 mol L–1.
Reduction of metronidazole and tinidazole
The adopted general approach to determining the best reducing agent for nitroimi-
dazoles involved reducing the MZ and TZ in 1,4-dioxan using the reduction systems:
Zn/HCl in ethanol at 90 °C, palladium-carbon/glacial acetic acid, LiBH4/glacial acetic
acid and NaBH4/glacial acetic acid at room temperature. In each case, 0.25 g of the re-
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ducing agent was incubated at appropriate temperature and the progress of reduction
was assessed at 5-minute intervals. The optimum time required for the reduction pro-
cess to go to completion was determined through the formation of salmon-pink colour
with DMAB, indicating the conversion of the nitro group to amine.
General procedure
A 5-mL volume of 7 ´ 10–3 mol L–1 solution of the reduced MZ or TZ solution (re-
duced with LiBH4 in methanol) was transferred to a 50-mL calibrated beaker, 5 mL of 0.1
mol L–1 NaNO2 solution was added and the mixture was stirred for 2 min. Then 5 mL of
0.2 mol L–1 sulfamic acid solution was added and stirred again for 1 min, all at 0 °C (iced).
Diazotized solutions were freshly prepared each day. Sample solutions for spot tests and
TLC were prepared by mixing 1.0 mL of the DMAB solution and 1 mL of the diazotized
drug. The colours obtained were recorded immediately and after 20 min. Solutions of
these azo adducts and that of DMAB were kept in a water bath (80 °C) and examined af-
ter 20 min.
The analytical wavelength was selected by recording the spectra of DMAB, the reac-
tion products with MZ and TZ as well as the spectra of diazotized MZ and TZ. The spectra
were overlaid on each other and the analytical wavelength was selected by inspection.
Temperature and time optimization was done using the method of steepest ascent
(18). This was carried out at 30, 50, 60 and 80 °C, after 5 and 20 minutes each. Eight test
tubes each containing 0.5 mL of 0.12 % (7 ´ 10–3 mol L–1) of reduced and diazotized me-
tronidazole (MZ) was used. p-DMAB solution (0.5 mL 0.1 %) was added to each of the
test tubes and vortexed. Methanol (4 mL) was added to each of the tubes to make up to 5
mL of reaction volume. At the end of the various reaction times and temperatures, the
absorbance reading of each of the mixtures was taken at 406 nm with methanol as blank
solvent. The same procedures were repeated for reduced and diazotized tinidazole (TZ)
at 404 nm. Optimization of the time required for coupling to take place at room tempera-
ture (30 °C) was done at 0, 2, 5, 10, 20 and 30 minutes. The reaction mixtures were made
up to 5 mL at these times with methanol, and the absorbance readings were taken at 406
nm and 404 nm (MZ and TZ, respectively) with methanol as blank.
The analytical signal stability was assessed by measuring the absorbance of the ad-
ducts at the working wavelengths at 5-minute intervals for the first 30 min, at 30-minute
intervals for the next three hours and then daily for 7 days.
Stoichiometric ratio determination
Job’s method of continuous variation (19) was used to determine the stoichiometric
ratios at which the diazotized imidazoles combine with DMAB. Various volumes of dia-
zotized solution of MZ/TZ were made up to 1.0 mL with the DMAB solution. The tubes
were kept at 30 °C for 2 min. At the end of the reaction time, methanol was added. The
absorbance readings were taken at 406 nm for MZ and at 404 nm for diazotized TZ.
Blank values were subtracted from that of the reaction mixture. All procedures were carried
in duplicate.
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Validation studies
Calibration curves were prepared using concentrations of diazotized MZ and TZ of
0, 4.8, 9.6, 19.2, 38.4 and 76.8 (0, 2.8, 5.6, 11.2, 22.4, 44.8 ´ 10–5 mol L–1 and 0, 1.9, 3.9, 7.8,
15.5, 31.1 ´ 10–5 mol L–1, respectively). 0.5 mL of 0.1 % (m/V) p-DMAB was added to
each of the tubes. These were allowed to stand for 2 minutes after which respective vol-
umes of methanol were added to make up to 5 mL of the reaction mixture. The
absorbance readings of each mixture were recorded at 406 and 404 nm, respectively.
The limit of detection (DL) and limits of quantitation (QL) were calculated accord-
ing to the current ICH guidelines (20) as 3.3 and 10 standard deviation of the blank (n =
6) divided by the slope of the calibration curve. Model recoveries and repeatability of
the new methods were carried out on three successive days as stipulated by the USP
(21). Accuracy was estimated at three concentration levels and 95 % confidence limits.
To study the potential interference from the commonly utilized tablet excipients and
other additives such as starch, lactose, magnesium stearate, talc, gelatin and their mix-
tures, recovery studies of 38.4 mg mL–1 (0.224 mmol L–1 and 0.155 mmol L–1, respecti-
vely) metronidazole and tinidazole from the matrices containing these excipients were
carried out. Four replicates were analyzed for each drug.
Assay of dosage forms
Three different brands of metronidazole tablets, one brand of infusion and one brand
of tinidazole tablets were analyzed. Mass uniformity test was carried out on the differ-
ent brands, and the active ingredient assay was then carried out based on the new me-
thod for each brand.
An amount of powdered tablets equivalent to 0.03 g of metronidazole and tinida-
zole was reduced with LiBH4 and then diazotized. A 0.16-mL aliquot of each of the re-
spective reduced and diazotized MZ and TZ stock solution (equivalent to 0.036 mmol
MZ and 0.025 mmol TZ) was then transferred into test tubes. 0.5 mL of 0.1 % p-DMAB
was added to each of the tubes. The reaction was allowed to proceed for 2 min after
which methanol (4 mL) was added. For MZ infusion, 6 mL of infusion solution was re-
duced and diazotized and 0.16 mL of the diazotized stock was used for coupling. The
absorbance reading of the respective reaction mixtures was recorded at 406 nm and 404
nm, respectively, for MZ and TZ using methanol as blank solvent. Official non-aqueous
titration (4) was adopted for MZ and TZ tablets and the UV spectrophotometric method




Metal hydrides were found to give the best results for the formation of the azo adduct
between diazotized nitroimidazoles and DMAB among the reducing agents studied. A
persistent yellowish-green colour was produced and was stable for seven days. This col-
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our is completely different from the salmon-pink produced after condensation reaction
between reduced nitroimidazoles and DMAB (16). This is the first paper to report the
use of DMAB as a coupling reagent in acidic solution. Since the dimethylamino moiety
in DMAB has a moderate activating influence on the aromatic skeleton, ortho substitu-
tion of an incoming electrophile might be possible. This reaction will be further aided by
the presence of the aldehyde group which is meta-directing. Thus the 3- and 5-positions
on the DMAB molecule are equivalent and will be available for electrophilic attack. This
was found true. This is illustrated in Scheme 1 showing the coupling of diazotized imi-
dazoles with DMAB. Fig. 1 presents the structures of the new compounds produced be-
tween DMAB and MZ and TZ. The possibility of steric hindrance on substitution by
diazotized nitroimidazoles is eliminated as the dimethylamino group is staggered from
the diazo linkage (bond angle between N8, C14 and C12 for the TZ adduct is 120.456°
and that of the MZ adduct between N 18, C 10 and C 4 is 122.665°). This shows that the
angles around a main chain nitrogen atom (the diazo linkage) are all approximately
equal to 120 degrees: consequently, the group is planar. Likewise, the torsion angles are
0.94 and 0.339°, respectively, for the TZ-DMAB and MZ-DMAB adducts. Since the tor-
sion is between 0 and +90°, the stereochemical arrangement is of the syn type. Both mole-
cules are therefore of the trigonal planar skeleton. Both the bond and torsion angles fa-
vour the formation of a stable adduct.
Thin layer chromatographic analyses using normal phase revealed the formation of
new adducts distinct from both DMAB and diazotized nitroimidazoles. The result of the
TLC analysis is presented in Table I. In both mobile phases adopted, the adducts were
more non-polar than the starting materials. This is expected, since conjugation of the ben-
zene ring with imidazoles should yield compounds with reduced polarity.
The overlaid absorption spectra of the drugs, DMAB and the new adducts are pre-
sented in Figs. 2a and b, respectively, for MZ and TZ. Coupling reaction of reduced and
diazotized nitroimidazoles with p-DMAB gave an instant greenish-yellow colour, indi-
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Fig. 1. Structures of the azo-adduct formed between DMAB and a) MZ and b) TZ.
Table I. Rf values of the thin layer chromatographic analysis
Mobile phase MZ-DMABa TZ-DMABa DMAB
Ethyl acetate/methanol (9:1) 0.90 (0.76) 0.91 (0.79) 0.83
Chloroform/acetone (8:2) 0.94 (0.33) 0.96 (0.60) 0.90
a Rf values for diazotized MZ and TZ in parentheses.
cating the formation of azo adduct. The reduced and diazotized nitroimidazoles exhib-
ited peaks at 210, 260, 360 nm (MZ) and 230, 300 and 350 nm (TZ). However, when re-
acted with p-DMAB, they formed azo dye of a characteristic greenish-yellow colour, as
shown by the results of the spot tests. The peaks for MZ adduct were at 310, 350, 370 nm
and a shoulder was at 406 nm while TZ adduct had a peak at 350 nm and a shoulder at
404 nm. The analytical wavelength was selected as 406 nm and 404 nm, respectively, rep-
resenting the wavelength where optimal detector response was obtained between DMAB
and the adduct with either MZ or TZ. Since diazotization is also a form of derivatiza-
tion, it was more convenient to use the shoulders at 406 and 404 nm, where diazotized
nitroimidazoles have very low absorptivity, without compromising the accuracy. The
slight difference in the absorption spectra of MZ and TZ can be attributed to the pres-
ence of different substituents on the molecules. Expectedly, the ethylsulfonylethyl frag-
ment in the TZ molecule should have a slight deactivating influence on the new adduct
compared to the ethanol moiety on MZ. However, the auxochromic effect is not very sig-
nificant as only a 2 nm difference was observed in absorption at the shoulder.
Optimization studies
Optimization of reducing agents revealed the superiority of metal hydrides over the
dissolving metals in glacial acid. The metal hydrides were used at room temperature as
compared to the use of elevated temperatures typical of Zn and Pd/C in ethanol or gla-
cial acetic acid reported by previous methods of Ahmed and Onah (9), Rehamn et al. (10)
and Siddappa et al. (16). Reduction was completed in 5 min using LiBH4. This is one of
the advantages of this report, which provides convenience of analysis.
The optimum coupling temperature and time for the coupling of diazotized MZ and
TZ with p-DMAB were established as 30 °C (room temperature) and 2 minutes. Higher
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Fig. 2. Absorption spectra of: a) DMAB, diazotized MZ and the adduct formed and b) DMAB, dia-
zotized TZ and the adduct formed.
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Proposed names of azo adducts
(a) 4-(dimethylamino)-3- ( )- 1-(2-hydroxyethyl)-2-methyl-1 -imidazol-5-yl diazenyl benzaldehyde





































(a) DMAB-MZ adduct (b) DMAB-TZ adduct
Step I: Reduction



































temperatures led to extremely low absorbance values. This implies that high tempera-
tures destroy the azo adduct formed between the compounds.
The study of analytical signal stability for the two azo adducts at 404 and 406 nm re-
vealed that absorbance was independent of time. The absorbance was constant over a
period of seven days, when measured daily, with a loss of only about 7.4 % for the MZ
adduct and 6.5 % for the TZ adduct.
The effect of water and methanol as diluting solvents was investigated after the coup-
ling reaction. When methanol was used as solvent, higher absorbance readings, better
regression equations, higher correlation coefficient and coefficient of determination were
obtained compared to the values when water was used. This ability of methanol to cause
high absorbance readings can be easily explained. The two processes leading to the cou-
pling reaction, reduction and diazotization involve removal of water molecules; hence,
any solvent that can sequester water molecules will favour the forward reaction, which
will also bring about the formation of more complex molecules. Thus, methanol was cho-
sen as the diluting solvent. It is also possible that the internal mesomeric effect within
the carbonyl group on the DMAB molecule might be active in water and might cause
some deactivation on the DMAB molecule. This reduces the possibility of coupling reac-
tion taking place. However, the polar effect is eliminated in methanol and the strong ac-
tivating influence of the dimethylamino fragment is optimal on thereby favouring the
coupling reaction.
Optimal detector response was obtained when the diazotized nitroimidazoles com-
bined at a mole ratio of 1:1 with DMAB as the coupling component. This corroborates
the TLC result and hence the structure presented in Scheme 1 is justified.
Validation
The new approach produced excellent correlation for the regression of absorbance
of the complex on the concentration of MZ (R2 = 0.9980) and TZ (R2 = 0.9983). Molar
absorptivities were 1.1 ´ 103 L mol–1 cm–1 and 1.3 ´ 103 L mol–1 cm–1 and limits of detec-
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Table II. Analytical and validation parameters for the assay of MZ and TZ
Parameter Metronidazole Tinidazole
Beer’s law limits (mg mL–1) 4.8–76.8 4.8–76.8
Limit of detection (mg mL–1) 1.41 1.94
Limit of quantitation (mg mL–1) 4.28 5.06
Molar absorptivity (L mol–1 cm–1) 1.1 ´ 103 1.3 ´ 103
Regression equationa
Intercept ± CI 0.0173 ± 0.0046 0.0125 ± 0.0041
Slope ± CI 0.0048 ± 0.00015 0.0048 ± 0.00013
Correlation coefficient, R 0.9990 0.9991
a Y = bX + a, where Y is the absorbance for concentration X (mg mL–1)
CI – confidence interval at p  0.05.
tion of 1.41 and 1.94 mg mL–1 and QLs of 4.28 and 5.06 mg mL–1 were obtained, respec-
tively, for MZ and TZ. The various validation parameters and optical properties for the
new procedures are presented in Table II. The overall model recoveries for MZ and TZ
adducts were in the order of 103.2 ± 1.3 % and 101.9 ± 1.3 %. The model recovery and re-
peatability of the new methods for the assay of MZ and TZ are presented in Table III. Ta-
ble IV contains the intra-day assessment of the accuracy and precision of the new me-
thod for the assay of nitroimidazoles. The mean recovery of the new method when com-
pared to the official method is presented in Table IV. The recovery for MZ ranged from
98.0–99.5 and for TZ it was 100.3 %, showing the suitability of the new method for the
analysis of metronidazole and tinidazole in dosage forms. One of the most promising
features of this new approach to the spectrophotometric determination of MZ and TZ is
the absence of interference from commonly utilized excipients in tablet formulations. The
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Table III. Model recovery and repeatability of the new method
Concentration
(mg mL–1)
Day 1a Day 2 a Day 3 a
Intermediate
precisionb
Mean recovery (%) Mean recovery (%) Mean recovery (%) RSD (%)
Metronidazole
9.6 104.1 ± 1.0 104.1 ± 1.0 101.90 ± 1.0 1.1
38.4 105.4 ± 0.3 104.8 ± 0.3 103.19 ± 0.8 0.6
76.8 101.5 ± 0.7 102.5 ± 1.0 101.78 ± 1.3 1.1
Tinidazole
9.6 101.0 ± 1.1 101.8 ± 0.9 101.47 ± 1.8 1.5
38.4 105.0 ± 0.7 100.4 ± 0.6 102.27 ± 2.0 1.2
76.8 102.6 ± 0.8 101.0 ± 0.4 100.94 ± 1.6 0.9
a n = 12
b n = 9
Table IV. Intra-day model accuracy and precision of the new method
Drug Added (mg mL–1) Founda ± CI (mg mL–1)a,b RSD (%)
MZ
9.6 9.9 ± 0.1 1.0
38.4 40.1 ± 0.3 0.9
76.8 78.3 ± 0.3 0.4
TZ
9.6 9.8 ± 0.01 0.1
38.4 38.9 ± 0.3 1.0
76.8 77.5 ± 0.1 0.02
a Mean ± SD for 6 determinations.
b Confidence limits for the concentrations found at p = 0.05 and 5 degrees of freedom.
recoveries obtained for MZ and TZ, respectively, in the presence of excipients are in the
order of 100.5–104.4 %. The results are presented in Table V. This lack of interference from
tablet excipients is another advantage of this new method.
Application of the new method
The applicability of the new method described in this report for the assay of me-
tronidazole infusion and tablets as well as tinidazole in tablets was examined and the re-
sults obtained were statistically compared with the official methods using F-ratio test,
t-test, confidence limits and ANOVA. The results are presented in Table VI. The recovery
of metronidazole and tinidazole from the dosage forms obtained by new method ranged
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Table VI. Determination of metronidazole and tinidazole in pharmaceutical preparations
Drug
formulation



















39.4 0.5 39.6 0.9 99.5 ± 0.6 0.5 1.13 1.06
Loxagyl
tablet
39.4 0.7 39.9 1.0 98.7 ± 0.6 1.3 4.36 2.09
Metrotab
tablet
39.3 1.2 40.1 1.1 98.0 ± 0.5 2.0 2.70 1.64
Tromet-500
infusion




39.5 0.8 39.4 0.7 100.3 ± 0.8 0.3 0.02 0.15
a Mean value, n = 6. Content of metronidazole tablet and that of infusion stipulated by BP = 95–105 %.
b Statistical analyses done between the results obtained from the proposed method and the BP official
non-aqueous titration (theoretical t-value = 2.776, theoretical F-value = 6.39).









MZ 103.6 ± 0.6 103.7 ± 0.4 103.3 ± 0.2 104.4 ± 1.4 103.3 ± 0.2 104.4 ± 0.6
TZ 100.5 ± 0.2 101.1 ± 0.2 100.8 ± 0.2 100.68 ± 0.3 100.4 ± 0.1 100.8 ± 0.2
a Concentration of each drug: 38.4 mg mL–1.
b Mean ± SD, n = 4.
between 98.0 and 100.3 % when compared with the official non-aqueons titrimetric pro-
cedure. Presented data suggest the ability of the new method to analyze metronidazole
and tinidazole in the tablet and infusion matrices with good accuracies and precision
comparable to that of official method.
CONCLUSIONS
The new approach of utilizing p-dimethylaminobenzaldehyde as a coupling compo-
nent is the first of such reports. The method adopted for the determination of nitroimi-
dazoles (metronidazole and tinidazole) is simple, accurate, sensitive, and less time-con-
suming and free from extreme experimental conditions such as heating at high
temperatures. It was successfully adopted for the analysis of these drugs in dosage
forms. Some obvious advantages of this new approach to the determination of nitro-imi-
dazoles include simplicity, accuracy, low cost and speed. Even though the method is a
two-step approach, it compared favourably with other previously reported methods.
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S A @ E T A K
Novi pristup spektrofotometrijskom odre|ivanju metronidazola i tinidazola
koriste}i p-dimetilaminobenzaldehid
OLAJIRE AREMU ADEGOKE i OFFIONG EDET UMOH
U radu je opisan novi na~in spektrofotometrijskog odre|ivanja metronidazola (MZ)
i tinidazola (TZ). Postupak uklju~uje reakciju diazotiranog nitroimidazola s p-dimetil-
aminobenzaldehidom (DMAB), pri ~emu nastaje zelenkasto-`uta otopina. Optimalna
temperatura i vrijeme za diazotaciju su 0 °C (ledena kupelj) i 3 minute, a za reakciju kon-
denzacije 30 °C i 2 minute. Obojeni adukti imaju maksimum apsorpcije pri 406, odnosno
404 nm pa su te valne duljine izabrane za analiti~ki postupak. Reakcija s p-DMAB zbiva
se u mno`inskom omjeru 1:1. Reakcija slijedi Beerov zakon u koncentracijskom rasponu
4,8–76,8 mg mL–1 s niskim granicama detekcije. Azo adukti su stabilni preko tjedan dana.
Molarna apsorptivnost bila je 1,10 ´ 103 (MZ), odnosno 1,30 ´ 103 L mol1 cm1 (TZ).
Ukupni povrat MZ i TZ iz kontrolnih uzoraka bio je 103,2 ± 1,3, odnosno 101,9 ± 1,3 %
tijekom tri dana. Nije zamije}ena nikakva interferencija uobi~ajenih pomo}nih tvari koje
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se koriste za tabletiranje. Ne postoji zna~ajna razlika izme|u rezultata dobivenih novom
metodom i rezultata dobivenih BP titrimetrijskim postupkom. Metoda odre|ivanja opi-
sana u ovom radu je jednostavna, brza, pogodna, to~na i precizna i po prvi puta uklju-
~uje DMAB u reakciji diazo kopulacije.
Klju~ne rije~i: nitroimidazoli, diazotacija, spektrofotometrija, p-dimetilaminobenzaldehid
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